I think it's marvelous, you know, as residents reacted to the news that Britain is on track to make Kovar 19 vaccines widely available by next spring.

It comes after the shot developed by Oxford University and AstraZeneca was found to be up to 90% effective in trials.

The encouraging late stage trial results were the third published among the seven vaccine candidates Britain has ordered following on from Pfizer, Biotech and Madonna.

Adrian Hill is the director of the Jenner Institute at Oxford University.

If you'd said to me a year ago that in 2020 anybody would make a vaccine for a global pandemic in months rather than years, I would have thought that that was hugely challenging and difficult.

Three groups have done it already.

There may be 1/4 by the end of the year.

It is quite remarkable on it can only happen if extraordinary support is provided on that.

Its support has bean forthcoming from all quarters.

Britain has secured 100 million doses of the AstraZeneca, shot 40 million of the fires of vaccine and five million of Madonna's candidate as the UK prepares to exit a national lock down next week, some are cautiously optimistic.

Speaking for myself, if I had to wait a bit longer just to make sure that it's all very safe, that would be fine.